Skip to content

Agilon Health AGL Book value per share

Book value per share at other companies

CVS Health logo
CVS HealthCVS
$60.56-0.5%
Astrana Health logo
Astrana HealthASTH
$16.31+6.9%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$5.75+11.5%
Alignment Healthcare logo
Alignment HealthcareALHC
$0.97+73.8%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$0.64-5.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$0.14+66.0%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.86B-92.6%
Enterprise value$1.69B-103%
P/S0.3×-3.9×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Calculated from Agilon Health’s reported figures.

Based on the most recent quarter.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's book value per share?
Agilon Health (AGL) reported book value per share of $10.89 in Q1 2026.
How has Agilon Health's book value per share changed year-over-year?
Agilon Health's book value per share decreased by 64.0% year-over-year, from $30.29 to $10.89.
What is the long-term trend for Agilon Health's book value per share?
Over 5 years (2020 to 2025), Agilon Health's book value per share has grown at a -19.0% compound annual growth rate (CAGR), from -$0.88 to $0.31.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.